MeVis Medical Solutions AGFRA:M3V +1.72%66 Pretax Margin % is 8.51% as of Mar. 2026, which is 74% below its 10-year median of 32.38. GuruFocus rates FRA:M3V with a GF Score™ of 66/100 and a GF Value™ of €22.52. The stock has 4 warning signs investors should review. Among 666 Healthcare Providers & Services companies, MeVis Medical Solutions AG ranks better than 70.27% on this metric.
The historical rank and industry rank for MeVis Medical Solutions AG's Pretax Margin % or its related term are showing as below:
FRA:M3V'
s Pretax Margin % Range Over the Past 10 Years
Min: 9.55 Med: 32.38 Max: 45.13
Current: 9.55
FRA:M3V's Pretax Margin % is ranked better than 70.27% of 666
companies
in the Healthcare Providers & Services industry
Industry Median: 4
vs FRA:M3V: 9.55
MeVis Medical Solutions AG (FRA:M3V) Pretax Margin % Explanation
The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.
The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.
It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.
The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.
MeVis Medical Solutions AG Pretax Margin % Related Terms
MeVis Medical Solutions AG Pretax Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:M3V vs VEEV, BTSG, TEM: Pretax Margin % Comparison
For the Health Information Services subindustry, MeVis Medical Solutions AG's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
MeVis Medical Solutions AG Pretax Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, MeVis Medical Solutions AG's Pretax Margin % distribution charts can be found below:
* The bar in red indicates where MeVis Medical Solutions AG's Pretax Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MeVis Medical Solutions AG (FRA:M3V) has a Pretax Margin % of 8.51% as of Mar. 2026. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on MeVis Medical Solutions AG and its competitors. This is 74% below median its historical median of 32.38. Over the past decade, MeVis Medical Solutions AG's Pretax Margin % has ranged from 9.55 to 45.13. According to the industry distribution chart, MeVis Medical Solutions AG ranks #198 out of 666 companies in the Healthcare Providers & Services industry, placing it in the top 29.7%.
Is MeVis Medical Solutions AG's Pretax Margin % too high?
MeVis Medical Solutions AG's current Pretax Margin % of 8.51% is 74% below median its 10-year median of 32.38. Over the past 10 years, this metric has ranged from a low of 9.55 to a high of 45.13. The Healthcare Providers & Services industry median Pretax Margin % is 4.00. MeVis Medical Solutions AG's value of 8.51% is 112.8% above this industry median. Based on the distribution chart, MeVis Medical Solutions AG ranks #198 out of 666 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, MeVis Medical Solutions AG has a GF Score™ of 66/100, reflecting its overall financial health beyond just this single metric.
How does MeVis Medical Solutions AG's Pretax Margin % compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, MeVis Medical Solutions AG ranks #198 out of 666 companies for Pretax Margin %. This puts MeVis Medical Solutions AG in the upper half of its industry. The industry median Pretax Margin % is 4.00. MeVis Medical Solutions AG's value of 8.51% is 112.8% above this benchmark. Historically, MeVis Medical Solutions AG's own Pretax Margin % has ranged from 9.55 to 45.13 over the past decade. While the company's 10-year median is 32.38 vs. the industry median of 4.00, MeVis Medical Solutions AG has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Healthcare Providers & Services company?
The median Pretax Margin % among Healthcare Providers & Services companies is 4.00, based on 666 companies in the industry. Companies in the top quartile (top 25%) have a Pretax Margin % significantly above this median, while those in the bottom quartile fall well below. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. MeVis Medical Solutions AG's current Pretax Margin % of 8.51% is 112.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on MeVis Medical Solutions AG and its competitors. For the Healthcare Providers & Services industry, the median Pretax Margin % is 4.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. MeVis Medical Solutions AG's current Pretax Margin % is 8.51%, which is 74% below median its own 10-year median of 32.38. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MeVis Medical Solutions AG stock overvalued right now?
MeVis Medical Solutions AG (FRA:M3V) has a current Pretax Margin % of 8.51%. The stock's GF Value™ is €22.52, compared to a current price of €23.60 — trading 4.8% above its estimated fair value. The current Pretax Margin % is 8.51%, which is 74% below median its 10-year median of 32.38 and 112.8% above the Healthcare Providers & Services industry median of 4.00. MeVis Medical Solutions AG's overall GF Score™ is 66/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For MeVis Medical Solutions AG (FRA:M3V), the current Pretax Margin % is 8.51% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is MeVis Medical Solutions AG (FRA:M3V) Overvalued in 2026?
Based on GuruFocus' analysis, MeVis Medical Solutions AG stock appears to be overvalued.
The current stock price of €23.60 is trading 4.8% above its estimated GF Value™ of €22.52.
Key valuation signals for FRA:M3V:
Pretax Margin %: 8.51% (74% below median its 10-year median of 32.38)
GF Value™: €22.52 vs. price of €23.60 (4.8% above fair value)
Industry Position: 112.8% above the Healthcare Providers & Services median (#198 of 666)
No single metric tells the full story. See the FRA:M3V stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
MeVis Medical Solutions AG is a provider of medical software products. The company markets its products to equipment manufacturer of medical devices and providers of medical information technology platforms. Its segment includes Digital mammography and Other diagnostics. The Digital mammography segment develops and markets software products which assist in breast diagnostic imaging and intervention. Its Other diagnostics segment consists of digital radiology products. In addition, it also provides the general analysis of radiology images. The company's geographical area of operations includes the United States of America and Europe.
66GF Score
Get the complete analysis for FRA:M3V
Pretax Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:M3V has been successfully added to your 
